Pharmacokinetic and Metabolic Analysis of Maoto

Pharmacokinetic and Metabolic Analysis of Maoto - Pharmacokinetic and Metabolic Analysis of Maoto

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000023609

Enrollment

Registered

2016-08-12

Start date

2016-08-12

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy adult

Interventions

Moat (TJ-27)

Eligibility

Sex/Gender

Male

Inclusion criteria

Inclusion criteria: (1) Japanese (2) Male (3) Age: 20 ~ 45 (4) BMI: 18.5 ~ 25.0 (5) Informed consent

Exclusion criteria

Exclusion criteria: (1) Allergy (2) Prticipate to other clinical trials within 16 weeks (3) Blood donation more than 400 ml within 12 weeks (4) Severe liver, heart or blood disease (5) Alchol and smooking (6) Drugs (7) Supllyments or diets which contains the ingredients of Maoto (8) Diagnosed as inappropriate by doctor (9) Positive HCV antibody, HBs antigen, and HIV antibody (10) Use of amphetamine and methamphetamine

Design outcomes

Primary

Measure	Time frame
Detect of ingredients delivers from Maoto in plasma.	—

Secondary

Measure	Time frame
Calculation of PK parameters and detect of ingredients delivers from Maoto in urine.	—

Countries

Japan

Contacts

Public ContactHiroyuki Kitagawa

Kochi Medical School Department of Surgery, Kochi Medical School

im31@kochi-u.ac.jp088-866-5811

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026